217 related articles for article (PubMed ID: 7943312)
1. Expression of components of the RAS during prolonged blockade at different levels in primates.
Samani NJ; Cumin F; Kelly M; Wood JM
Am J Physiol; 1994 Oct; 267(4 Pt 1):E612-9. PubMed ID: 7943312
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
Schunkert H; Ingelfinger JR; Jacob H; Jackson B; Bouyounes B; Dzau VJ
Am J Physiol; 1992 Nov; 263(5 Pt 1):E863-9. PubMed ID: 1443118
[TBL] [Abstract][Full Text] [Related]
3. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
Wood JM; Schnell CR; Cumin F; Menard J; Webb RL
J Hypertens; 2005 Feb; 23(2):417-26. PubMed ID: 15662231
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat.
Sechi LA; Griffin CA; Giacchetti G; Valentin JP; Llorens-Cortes C; Corvol P; Schambelan M
Hypertension; 1996 Sep; 28(3):403-8. PubMed ID: 8794824
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation.
Bo Yang ; Chen YD; Li TD; Feng QZ
J Renin Angiotensin Aldosterone Syst; 2010 Jun; 11(2):119-23. PubMed ID: 20093323
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R
Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.
Scheidegger KJ; Wood JM; van Essen H; Struijker-Boudier HA
J Pharmacol Exp Ther; 1996 Sep; 278(3):1276-81. PubMed ID: 8819512
[TBL] [Abstract][Full Text] [Related]
8. Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system.
Scheidegger KJ; Nelissen-Vrancken MH; Leenders PJ; Daemen MJ; Smits JF; Wood JM
J Hypertens; 1997 Dec; 15(12 Pt 1):1455-62. PubMed ID: 9431852
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
[TBL] [Abstract][Full Text] [Related]
10. Biochemical effects of prolonged renin inhibition in marmosets.
Wood JM; Jobber RA; Baum HP; de Gasparo M; Nussberger J
J Hypertens; 1989 Aug; 7(8):615-8. PubMed ID: 2681408
[TBL] [Abstract][Full Text] [Related]
11. [The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet].
Chen YH; Yuan L; Chen YY; Qi CJ
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):197-201. PubMed ID: 18785501
[TBL] [Abstract][Full Text] [Related]
12. Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis.
Dechow C; Morath C; Peters J; Lehrke I; Waldherr R; Haxsen V; Ritz E; Wagner J
Am J Physiol Renal Physiol; 2001 Nov; 281(5):F909-19. PubMed ID: 11592949
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats.
Webb RL; Navarrete AE; Davis S; de Gasparo M
J Hypertens; 1998 Jun; 16(6):843-52. PubMed ID: 9663925
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of the renin system by aliskiren and valsartan.
Birkenhäger WH; Staessen JA
Lancet; 2007 Jul; 370(9583):195-196. PubMed ID: 17658374
[No Abstract] [Full Text] [Related]
15. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
Siragy HM; Xue C; Abadir P; Carey RM
Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
[TBL] [Abstract][Full Text] [Related]
17. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes.
Fukamizu A; Sugimura K; Takimoto E; Sugiyama F; Seo MS; Takahashi S; Hatae T; Kajiwara N; Yagami K; Murakami K
J Biol Chem; 1993 Jun; 268(16):11617-21. PubMed ID: 8505294
[TBL] [Abstract][Full Text] [Related]
18. Changes in the maternal and fetal renin-angiotensin systems in response to angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
Forhead AJ; Broughton Pipkin F; Sutherland MF; Fowden AL
Exp Physiol; 1997 Jul; 82(4):761-76. PubMed ID: 9257117
[TBL] [Abstract][Full Text] [Related]
19. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
Chow L; De Gasparo M; Levens N
Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292
[TBL] [Abstract][Full Text] [Related]
20. Suppression of endotoxin-induced renal tumor necrosis factor-alpha and interleukin-6 mRNA by renin-angiotensin system inhibitors.
Niimi R; Nakamura A; Yanagawa Y
Jpn J Pharmacol; 2002 Feb; 88(2):139-45. PubMed ID: 11928713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
